{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:07:03Z","timestamp":1791281223074,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T00:00:00Z","timestamp":1282521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0012357","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T16:47:07Z","timestamp":1282582027000},"page":"e12357","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Survival of the Fittest: Positive Selection of CD4+ T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection"],"prefix":"10.1371","volume":"5","author":[{"given":"Janine","family":"Kimpel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay Eng","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Conolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn E.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent M.","family":"Humeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boro","family":"Dropulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"von Laer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Paul","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,8,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.","volume":"366","author":"JA Sterne","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2008.02687.x","article-title":"Drug-resistant human immunodefiency virus.","volume":"15","author":"MJ Kozal","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"ref3","first-page":"197","article-title":"Future implications: compliance and failure with antiretroviral treatment.","volume":"52","author":"AK Patel","year":"2006","journal-title":"J Postgrad Med"},{"key":"ref4","first-page":"229","article-title":"Adverse effects of antiretroviral therapy for HIV infection.","volume":"170","author":"V Montessori","year":"2004","journal-title":"CMAJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2741\/1841","article-title":"Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques.","volume":"11","author":"SE Braun","year":"2006","journal-title":"Front Biosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/hum.2006.17.577","article-title":"Gene-based immunotherapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome.","volume":"17","author":"B Dropulic","year":"2006","journal-title":"Human Gene Therapy"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nbt1367","article-title":"Genetic therapies against HIV.","volume":"25","author":"JJ Rossi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.","volume":"26","author":"EE Perez","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JVI.78.2.568-575.2004","article-title":"Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides.","volume":"78","author":"M Egelhofer","year":"2004","journal-title":"J Virol"},{"key":"ref10","first-page":"500","article-title":"Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.","volume":"19","author":"NS Lee","year":"2002","journal-title":"Nat Biotechnol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ymthe.2005.07.524","article-title":"Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.","volume":"12","author":"MJ Li","year":"2005","journal-title":"Mol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1128\/JVI.78.13.7079-7088.2004","article-title":"Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance.","volume":"78","author":"X Lu","year":"2004","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtbi.2005.05.005","article-title":"Impact of gene-modified T cells on HIV infection dynamics.","volume":"238","author":"D von Laer","year":"2006","journal-title":"J Theor Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector.","volume":"103","author":"BL Levine","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jgm.705","article-title":"Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients.","volume":"7","author":"JL Macpherson","year":"2005","journal-title":"J Gene Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.2005.16.1065","article-title":"Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.","volume":"16","author":"RA Morgan","year":"2005","journal-title":"Hum Gene Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1073\/pnas.93.7.2889","article-title":"Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.","volume":"93","author":"C Woffendin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/mt.sj.6300124","article-title":"Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus.","volume":"15","author":"J van Lunzen","year":"2007","journal-title":"Mol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/104303404322886101","article-title":"Anti-human immunodeficiency virus hematopoietic progenitor cell-delievered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.","volume":"15","author":"RG Amado","year":"2004","journal-title":"Hum Gene Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.02.024","article-title":"Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells.","volume":"12","author":"GM Podsakoff","year":"2005","journal-title":"Mol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation.","volume":"360","author":"G Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ng0597-100","article-title":"Global distribution of the CCR5 gene 32-basepair deletion.","volume":"16","author":"JJ Martinson","year":"1997","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/JVI.75.6.3038-3042.2001","article-title":"Membrane-anchored peptide inhibits human immunodeficiency virus entry.","volume":"75","author":"M Hildinger","year":"2001","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.","volume":"2","author":"DL DiGiusto","year":"2010","journal-title":"Science Translational Medicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ymthe.2004.03.005","article-title":"Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load.","volume":"9","author":"L Humeau","year":"2004","journal-title":"Mol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/hum.2006.158","article-title":"Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptides.","volume":"20","author":"FG Hermann","year":"2009","journal-title":"Hum Gene Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1073\/pnas.0705474104","article-title":"Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates.","volume":"104","author":"DS An","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/sj.gt.3302801","article-title":"T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.","volume":"13","author":"CH Swan","year":"2006","journal-title":"Gene Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.smim.2008.04.002","article-title":"The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche.","volume":"20","author":"JD Estes","year":"2008","journal-title":"Semin Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/mt.2009.316","article-title":"HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model.","volume":"18","author":"R Mukherjee","year":"2010","journal-title":"Mol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/10430340252898984","article-title":"High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.","volume":"13","author":"C Demaison","year":"2002","journal-title":"Hum Gene Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/jgm.593","article-title":"Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.","volume":"6","author":"X Lu","year":"2004","journal-title":"J Gene Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.","volume":"15","author":"R Zufferey","year":"1997","journal-title":"Nat Biotechnol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/JVI.76.3.1488-1495.2002","article-title":"Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.","volume":"76","author":"WR Beyer","year":"2002","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/gt.2008.73","article-title":"Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides.","volume":"15","author":"RC Zahn","year":"2008","journal-title":"Gene Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ymthe.2005.07.698","article-title":"Inhibition of simian\/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.","volume":"12","author":"SE Braun","year":"2005","journal-title":"Mol Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0684.1992.tb00589.x","article-title":"Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates.","volume":"21","author":"JR Higgins","year":"1992","journal-title":"J Med Primatol"},{"key":"ref38","first-page":"92","article-title":"HIV-infected cell fusion assay.","author":"VA Johnson","year":"1990"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1128\/JVI.79.16.10237-10246.2005","article-title":"Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides.","volume":"79","author":"S Lohrengel","year":"2005","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0012357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T22:03:20Z","timestamp":1636236200000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0012357"}},"subtitle":[],"editor":[{"given":"Jean-Pierre","family":"Vartanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,23]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0012357","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,23]]}}}